HF
ORMP icon

HRT Financial’s Oramed Pharmaceuticals ORMP Stock Holding History

HRT Financial’s Portfolio ORMP Stock Details ORMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$469K Buy
97,582
+70,084
+255% +$279K ﹤0.01% 2736
2026
Q1 		$93K Sell
27,498
-18,593
-40% -$63.1K ﹤0.01% 3363
2025
Q4 		$131K Buy
+46,091
New +$119K ﹤0.01% 2738
2024
Q1 		– Sell
-11,165
Closed -$25K – 2875
2023
Q4 		$25K Buy
+11,165
New +$23.8K ﹤0.01% 2020
2023
Q2 		– Sell
-45,035
Closed -$98K – 3033
2023
Q1 		$98K Buy
+45,035
New +$143K ﹤0.01% 2063
2022
Q1 		– Sell
-64,198
Closed -$916K – 3650
2021
Q4 		$916K Buy
+64,198
New +$1.34M 0.01% 1215

Other funds holding ORMP

Mercer Global Advisors
Mercer Global Advisors Denver, Colorado $80.9B AUM 26.08% 1-Year Est. Return
AF
Aquamarine Financial George Town $1.81B AUM 38.21% 1-Year Est. Return
GIA
Gem Investment Advisors Teaneck, New Jersey $163M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
M
Murchinson Toronto, Ontario, Canada $725M AUM 82.02% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

HRT Financial's ORMP Position: Q2 2026 in Review

HRT Financial increased its Oramed Pharmaceuticals (ORMP) stake by 255% in Q2 2026, buying an estimated $279K and bringing the position to 97,582 shares worth $469K. The position accounts for ﹤0.01% of the portfolio, ranked #2736.

HRT Financial first reported a position in ORMP in Q4 2021 and has held it in 6 quarters since. The position peaked at $916K in Q4 2021. 84 funds tracked by Wall St. Rank hold ORMP as of Q2 2026.

  • HRT Financial held 97,582 shares of Oramed Pharmaceuticals worth $469K as of Q2 2026.
  • HRT Financial bought 70,084 Oramed Pharmaceuticals shares in Q2 2026, an estimated $279K.
  • Oramed Pharmaceuticals made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #2736 holding.
  • HRT Financial first reported a position in Oramed Pharmaceuticals in Q4 2021 and has held it in 6 quarters since.
  • HRT Financial's Oramed Pharmaceuticals position peaked at $916K in Q4 2021.
  • 84 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.